Financing channel feed – Endpoints News

Financing channel feed

ARCH leads $130M infusion into Be Bio's long pursuit of B cell therapies for rare disease, cancer

4 years ago

'Truly different': Roche's former hematology leader shifts a new Versant biotech into gear

4 years ago

RA, Jeito and Omega back a small Swiss biotech to enter an I/O field paved by Adaptimmune

4 years ago

Stanford spinout racks up more support for its mRNA approach to cellular rejuvenation

4 years ago

‘Don’t want to fuss with this stuff’: Another DNA synthesis startup reels in funding

4 years ago

Pharma vets with Genentech connection band together to launch new immunotherapy startup, though details are scant

4 years ago

Facing empty reserves by year's end, Lyra is raising nearly double its 2020 IPO as it enters PhIII

4 years ago

RA, Atlas-backed biotech spins up with $110M in pursuit of protein degradation via molecular glues

4 years ago

With an eye to 'non-obvious binding sites,' CBC Group launches precision medicine play with $67M and ex-Editas exec at the helm

4 years ago

Two biotechs press forward with IPOs in a bid to stir market from hibernation

4 years ago

A new anti-aging biotech wants to add 10 years to your life. But who's funding it?

4 years ago

5AM dashes out of the gate, kicking off Q2 with $750M in two new funds

4 years ago

AMR Action Fund looks to tackle antimicrobial resistance with first two investments — but does the money arrive too late?

4 years ago

Belgian VC behind AbbVie-owned Syndesi closes second investment fund, securing nine-figure raise

4 years ago

Cosela maker's early employees aim to replicate 'blueprint' at a new biotech — with an old G1 asset

4 years ago

Attention biotech history: Ginkgo pours $700M+ on just 2 execs

4 years ago

Luca Santarelli's VectivBio bags $100M-plus in new funding from licensing pact, loan

4 years ago

Chasing Bristol Myers and Biogen/Denali, CNS biotech raises $100M in dash toward clinic

4 years ago

ConcertAI sings a unicorn tune as the FDA-partnered clinical trials software upstart expands

4 years ago

As shares skyrocket on Sanofi deal, IGM Biosciences looks to bag $200M

4 years ago

Another RA-backed biotech hits Nasdaq as public market stirs again after a bruising first quarter

4 years ago

Public biotechs raising funds? In this economy? A trio of companies brings $1.5B+ to battered sector after PhIII wins

4 years ago

Celsius aims to cool down inflammation with new investors and more pharma deals

4 years ago

Greg Verdine will have many new C-suite friends at fungus biotech LifeMine after GSK-fueled $175M round

4 years ago

First page Previous page 56 57 585960 61 62 Next page Last page